Cybin Inc
Change company Symbol lookup
Select an option...
CLXPF Cybin Inc
RVVTF Revive Therapeutics Ltd
SHRMF Braxia Scientific Corp
LKYSF Numinus Wellness Inc
MNMD Mind Medicine (MindMed) Inc
CMPS Compass Pathways PLC
TLIS Talis Biomedical Corp
DVN Devon Energy Corp
BCX BlackRock Resources & Commodities Strategy Trust
BRKS Brooks Automation Inc

Based in Canada
Company profile

Cybin Inc., formerly Clarmin Explorations Inc., is a Canada-based life sciences company. The Company is focused on developing psychedelic pharmaceutical and non-psychedelic nutraceutical-based products. Its subsidiaries include Natures Journey Inc. and Serenity Life Sciences Inc. Serenity Life Sciences Inc. is focused on research and development of psilocybin-based medications. Natures Journey Inc. operates the Journey brand, which specializes in developing medicinal mushroom products. It has a drug delivery platform developed to administer psychedelic therapies and bypass liver metabolism. The Company also focus is on the development of treatment regimens consisting of psychedelic molecules and related clinical protocols.

Day's Change
-0.01 (-0.61%)
B/A Size
Day's High
Day's Low

Today's volume of 211,237 shares is on pace to be much lighter than CLXPF's 10-day average volume of 781,796 shares.


3M stock a rare Dow gainer amid broad selloff after winning patent infringement case in China

1:17 pm ET February 25, 2021 (MarketWatch)

Shares of 3M Co. (MMM) gained 0.4% in afternoon trading, and were the biggest gainer of the only two Dow Jones Industrial Average components gaining ground, amid a broad-market selloff after the consumer, health care and industrial products company announced a positive outcome in its patent infringement case against in China. The company said the Intermediate People's Court of Zhengzhou has ordered Qingdao Sisa Abrasives Co. Ltd. to immediately stop making and selling its infringing abrasive grain in China as it infringes 3M's patents in China. The court also directed Qingdao Sisa to compensate 3M for its economic losses and expenses, but the amount of compensation was not disclosed. The other Dow gainer was Nike Inc.'s stock (NKE), which rose 0.2%. The other 28 Dow stocks were down between 0.4% and 4.8%. Meanwhile, the Dow tumbled 513 points, or 1.6%.

-Tomi Kilgore; 415-439-6400;


(END) Dow Jones Newswires

February 25, 2021 13:17 ET (18:17 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.